NEW YORK (GenomeWeb News) – Biosimulation firm Entelos said today that it expects its fourth-quarter and full-year revenues to be below previous estimates.
 
“The current economic crisis has impacted almost every industry including our customer segment,” Entelos said in a statement. “Many of our pharmaceutical customers have recently announced delays in some of their internal drug development programs.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.